Skip to content

A research study in Pakistan to test an intervention called DIALOG+, designed to improve care for people living in the community with common mental disorders

Testing the effectiveness, acceptability and feasibility of DIALOG+ in common mental disorders in Pakistan: a non-controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14528579
Enrollment
44
Registered
2019-06-06
Start date
2019-06-03
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Common mental disorders (mild-moderate depression and anxiety) Mental and Behavioural Disorders

Interventions

4 counsellors, and 40 patients who are eligible to receive the Pursukoon Zindangi (Peaceful Life) counselling programme will be recruited. Patients will receive DIALOG+ at their routine counselling ap

Sponsors

Queen Mary University of London
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Score of 20-60 on the AKUADS scaled for the symptoms of mild to moderate anxiety and depression 2. Aged 18-65 years old 3. Lives within a 20 km radius of the clinic where recruitment will take place 4. Capacity to provide informed consent 5. Score of 5 or below on the MANSA scale 6. Able to communicate in Urdu 7. Enrolled for individual counselling with the Pusukoon Zindagi (Peaceful Life) programme

Exclusion criteria

Exclusion criteria: 1. Does not meet inclusion criteria 2. Primary diagnosis of substance-use disorder; organic psychosis and/or neurocognitive disorder 3. Participating in another interventional study by this or another research group

Design outcomes

Primary

MeasureTime frame
Quality of life measured using the Manchester Short Assessment of Quality of Life (MANSA) at baseline and 6 months

Secondary

MeasureTime frame
1. Objective social functioning measured using Objective Social Outcome Index (SIX) at baseline and 6 months 2. Symptoms measured using Aga Khan University Anxiety and Depression Scale (AKUADS) at baseline and 6 months

Countries

Pakistan

Contacts

Public ContactFrancois van Loggerenberg
f.vanloggerenberg@qmul.ac.uk+44 (0)207 540 4380 Ext: 2339

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: May 1, 2026